Melbourne R Talactac Selected Research

Human Influenza (Influenza)

2/2014	Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice.
12/2013	The highly conserved HA2 protein of the influenza A virus induces a cross protective immune response.
12/2012	Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
4/2012	Induction of type I interferon by high-molecular poly-γ-glutamate protects B6.A2G-Mx1 mice against influenza A virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Melbourne R Talactac Research Topics

Disease

4	Human Influenza (Influenza) 02/2014 - 04/2012
2	Virus Diseases (Viral Diseases) 01/2015 - 04/2012
1	Vesicular Stomatitis 01/2015
1	Infections 02/2014

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2015 - 12/2012
2	Antiviral Agents (Antivirals)IBA 01/2015 - 04/2012
2	Influenza Vaccines (Influenza Vaccine)FDA Link 02/2014 - 12/2012
2	VaccinesIBA 12/2013 - 04/2012
2	Prostaglandins AIBA 12/2012 - 04/2012
1	CytokinesIBA 01/2015
1	Interferon Type IIBA 01/2015
1	Plant ExtractsIBA 01/2015
1	Peptides (Polypeptides)IBA 12/2013
1	AntibodiesIBA 12/2013
1	Surface Antigens (Surface Antigen)IBA 12/2013
1	Recombinant ProteinsIBA 12/2013
1	poly(gamma-glutamic acid) (gamma-PGA)IBA 12/2012
1	Hemagglutinins (Hemagglutinin)IBA 12/2012
1	AntigensIBA 12/2012
1	Glutamic Acid (Glutamate)FDA Link 12/2012
1	ChitosanIBA 12/2012

Therapy/Procedure

1	Intranasal Administration 12/2012